Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer
Vascular-targeted photodynamic therapy (VTP) induces rapid destruction of targeted tissues and is a promising therapy for prostate cancer.However, the resulting immune response, which may play an important role in either potentiating or blunting the effects of VTP, is still incompletely understood.Myeloid cells such as read more myeloid-derived sup